NEW YORK, Nov. 18 (GenomeWeb News) - CuraGen subsidiary 454 Life Sciences is offering a glimpse of one aspect of its next-generation sequencing technology, which has been under development - and under wraps - since 454's spin-out in 2000. The company said today that it has published its method to amplify genome fragments for sequencing in its massively parallel platform.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.